9 institutional investors and hedge funds own CHYM, holding 43,205,620 shares worth $809.2M (latest 13F filings).
Institutional holders of CHYM — largest position first.
Super Fund | Position | Shares | Curr. Value | Port. % | Activity |
|---|---|---|---|---|---|
| Tiger Global Management | Equity | 11,081,780 | $207,561,740 | 0.91% | -21.92% |
| Coatue Management | Equity | 10,071,992 | $188,648,409 | 0.65% | 0% |
| Softbank Group Corp | Equity | 5,067,336 | $94,911,203 | 0.83% | 0% |
| Dragoneer Investment Group | Equity | 4,308,999 | $80,707,551 | 2.69% | -49.60% |
| SCGE Management | Equity | 4,181,827 | $78,325,620 | 2.37% | -5.41% |
| Patient Capital Management | Equity | 2,882,016 | $53,980,161 | 2.01% | +41.61% |
| Davis Selected Advisers | Equity | 2,539,206 | $47,559,328 | 0.22% | +2.71% |
| Atreides Management | Equity | 1,622,734 | $30,393,808 | 0.74% | +7.91% |
| SC US (TTGP) | Equity | 1,449,730 | $27,153,443 | 0.30% | 0% |